发明申请
US20070015737A1 Compounds for inhibiting diseases and preparing cells for transplantation
审中-公开
用于抑制疾病和制备移植细胞的化合物
- 专利标题: Compounds for inhibiting diseases and preparing cells for transplantation
- 专利标题(中): 用于抑制疾病和制备移植细胞的化合物
-
申请号: US11265537申请日: 2005-11-02
-
公开(公告)号: US20070015737A1公开(公告)日: 2007-01-18
- 发明人: Anne Clark , Paul Fraser , Bruce Verchere , Ajay Gupta , David Migneault , Walter Szarek
- 申请人: Anne Clark , Paul Fraser , Bruce Verchere , Ajay Gupta , David Migneault , Walter Szarek
- 申请人地址: CH Lausanne GB Oxford CA Kingston CA Vancouver
- 专利权人: Neurochem (International) Limited,Isis Innovation Limited,Queen's University at Kingston,The University of British Columbia,The Governing Counsel of The University of Toronto
- 当前专利权人: Neurochem (International) Limited,Isis Innovation Limited,Queen's University at Kingston,The University of British Columbia,The Governing Counsel of The University of Toronto
- 当前专利权人地址: CH Lausanne GB Oxford CA Kingston CA Vancouver
- 优先权: GB9916214.1 19990709; GB9916315.6 19990712
- 主分类号: A61K31/66
- IPC分类号: A61K31/66 ; G01N33/567 ; A61K31/44 ; A61K31/47 ; A61K31/445 ; A61K31/185 ; C12N5/08 ; A61K31/19 ; G01N33/53
摘要:
Methods and compositions which are useful in the treatment of amyloidosis. In particular, methods and compositions are provided for inhibiting, preventing and treating amyloid depositions, e.g. in pancreatic islets, wherein the amyloidotic deposits are islet amyloid polypeptide (IAPP)-associated amyloid deposition or deposits. The methods of the invention involved administering to a subject a therapeutic compound which inhibits IAPP-associated amyloid deposits. Accordingly, the compositions and method of the invention are useful for inhibiting IAPP-associated amyloidosis in disorders in which such amyloid deposition occurs, such an diabetes. The invention also provides a process for the preparation of cells suitable for transplantation into a mammal, which cells are capable of forming fibrils, said process comprising contacting the cells with an inhibitor of fibril formation. In particular the process prepares cells for use in a method of treating diabetes. Also provided are a culture medium comprising the inhibitor and cells for transplantation.
信息查询